Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Feb;47(2):429–433. doi: 10.1128/iai.47.2.429-433.1985

Effect of liposomal amphotericin B on murine macrophages and lymphocytes.

R T Mehta, K Mehta, G Lopez-Berestein, R L Juliano
PMCID: PMC263187  PMID: 2578433

Abstract

The effect of liposome-encapsulated amphotericin B on mouse macrophages and on T- and B-lymphocyte functions in vitro was compared with that of free amphotericin B. Liposomal amphotericin B was generally less toxic than the free form of the drug. Low concentrations of free amphotericin B completely inhibited the serum-dependent induction of transglutaminase, a marker for macrophage differentiation, and production of superoxide anion by macrophages, whereas encapsulation of the drug within liposomes protected the cells from these adverse effects. Liposomal amphotericin B did not affect the blastogenic response of T cells compared with the free drug, which was inhibitory at high concentrations. Antibody production in vivo was inhibited partially by both free and liposomal amphotericin B. These results thus suggest that encapsulation of amphotericin B in liposomes reduces the immunosuppressive effects exerted by free amphotericin B. This provides further justification for therapeutic use of liposomal amphotericin B in systemic fungal infections (G. Lopez-Berestein, R. Mehta, R. L. Hopfer, K. Mills, L. Kasi, K. Mehta, V. Fainstein, M. Luna, E. M. Hersh, and R. L. Juliano, J. Infect. Dis. 147:939-945, 1983).

Full text

PDF
429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapman H. A., Jr, Hibbs J. B., Jr Modulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage function. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4349–4353. doi: 10.1073/pnas.75.9.4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hadfield T. L., Marcus S. Macrophage and lymphocyte contributions in resistance of Candida albicans infections. Immunol Commun. 1982;11(3):201–216. doi: 10.3109/08820138209094131. [DOI] [PubMed] [Google Scholar]
  3. Hammarström L., Smith E. Mitogenic properties of polyene antibiotics for murine B cells. Scand J Immunol. 1976;5(1-2):37–43. doi: 10.1111/j.1365-3083.1976.tb02990.x. [DOI] [PubMed] [Google Scholar]
  4. Hauser W. E., Jr, Remington J. S. Effect of amphotericin B on natural killer cell activity in vitro. J Antimicrob Chemother. 1983 Mar;11(3):257–262. doi: 10.1093/jac/11.3.257. [DOI] [PubMed] [Google Scholar]
  5. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  6. Lin S. H., Medoff G., Kobayashi G. S. Effects of amphotericin B on macrophages and their precursor cells. Antimicrob Agents Chemother. 1977 Jan;11(1):154–160. doi: 10.1128/aac.11.1.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Little J. R., Abegg A., Plut E. The relationship between adjuvant and mitogenic effects of amphotericin methyl ester. Cell Immunol. 1983 Jun;78(2):224–235. doi: 10.1016/0008-8749(83)90277-0. [DOI] [PubMed] [Google Scholar]
  8. Lohr K. M., Snyderman R. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes. J Immunol. 1982 Oct;129(4):1594–1599. [PubMed] [Google Scholar]
  9. Lopez-Berestein G., Hopfer R. L., Mehta R., Mehta K., Hersh E. M., Juliano R. L. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob Agents Chemother. 1984 Mar;25(3):366–367. doi: 10.1128/aac.25.3.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lopez-Berestein G., Mehta K., Mehta R., Juliano R. L., Hersh E. M. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues. J Immunol. 1983 Apr;130(4):1500–1502. [PubMed] [Google Scholar]
  11. Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May;147(5):939–945. doi: 10.1093/infdis/147.5.939. [DOI] [PubMed] [Google Scholar]
  12. Lorand L., Rule N. G., Ong H. H., Furlanetto R., Jacobsen A., Downey J., Oner N., Bruner-Lorand J. Amine specificity in transpeptidation. Inhibition of fibrin cross-linking. Biochemistry. 1968 Mar;7(3):1214–1223. doi: 10.1021/bi00843a043. [DOI] [PubMed] [Google Scholar]
  13. Medoff G., Brajtburg J., Kobayashi G. S., Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol. 1983;23:303–330. doi: 10.1146/annurev.pa.23.040183.001511. [DOI] [PubMed] [Google Scholar]
  14. Mehta K., Juliano R. L., Lopez-Berestein G. Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. Immunology. 1984 Mar;51(3):517–527. [PMC free article] [PubMed] [Google Scholar]
  15. Mehta K., Murtaugh M. P., Juliano R. L., Davies P. J. Phagocytosis inhibits the expression of tissue transglutaminase in mouse peritoneal macrophages. J Immunol. 1984 May;132(5):2552–2558. [PubMed] [Google Scholar]
  16. Mehta K., Sindhu R. K., Subrahmanyam D., Nelson D. S. IgE-dependent adherence and cytotoxicity of rat spleen and peritoneal cells to Litomosoides carinii microfilariae. Clin Exp Immunol. 1980 Jul;41(1):107–114. [PMC free article] [PubMed] [Google Scholar]
  17. Mehta R., Lopez-Berestein G., Hopfer R., Mills K., Juliano R. L. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta. 1984 Mar 14;770(2):230–234. doi: 10.1016/0005-2736(84)90135-4. [DOI] [PubMed] [Google Scholar]
  18. Murtaugh M. P., Mehta K., Johnson J., Myers M., Juliano R. L., Davies P. J. Induction of tissue transglutaminase in mouse peritoneal macrophages. J Biol Chem. 1983 Sep 25;258(18):11074–11081. [PubMed] [Google Scholar]
  19. Pabst M. J., Johnston R. B., Jr Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med. 1980 Jan 1;151(1):101–114. doi: 10.1084/jem.151.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Roselle G. A., Kauffman C. A. Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity. Clin Exp Immunol. 1980 Apr;40(1):186–192. [PMC free article] [PubMed] [Google Scholar]
  21. Shirley S. F., Little J. R. Immunopotentiating effects of amphotericin B. II. Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol. 1979 Dec;123(6):2883–2889. [PubMed] [Google Scholar]
  22. Stewart S. J., Spagnuolo P. J., Ellner J. J. Generation of suppressor T lymphocytes and monocytes by amphotericin B. J Immunol. 1981 Jul;127(1):135–139. [PubMed] [Google Scholar]
  23. Tucker S. B., Pierre R. V., Jordon R. E. Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods. 1977;14(3-4):267–269. doi: 10.1016/0022-1759(77)90137-5. [DOI] [PubMed] [Google Scholar]
  24. Vertut-Croquin A., Bolard J., Chabbert M., Gary-Bobo C. Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study. Biochemistry. 1983 Jun 7;22(12):2939–2944. doi: 10.1021/bi00281a024. [DOI] [PubMed] [Google Scholar]
  25. Walls E. V., Kay J. E. Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone). Immunology. 1982 Sep;47(1):115–121. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES